1996
DOI: 10.1046/j.1471-4159.1996.66020834.x
|View full text |Cite
|
Sign up to set email alerts
|

The Lex Carbohydrate Sequence Is Recognized by Antibody to L5, a Functional Antigen in Early Neural Development

Abstract: The L5 antigenic determinant was previously suggested to be a carbohydrate epitope present on murine cell recognition molecules in the developing brain and to be an early neural marker in the chick embryo. Here, we show that L5 immunoreactivity is associated with complex-type N-glycosidic oligosaccharides. To identify the carbohydrate structure recognized by the L5 antibody, we investigate its binding to N-linked oligosaccharides derived from L5 glycoproteins and to known glycans. Results of mass spectrometric… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
34
0

Year Published

1998
1998
2018
2018

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 83 publications
(37 citation statements)
references
References 50 publications
1
34
0
Order By: Relevance
“…Polyclonal antibodies to mouse L1 (Chen et al, 1999), NCAM (Kadmon et al, 1992), Contactin (R&D Systems), TAG-1 [TG3, Traka et al, (2003) and from R&D Systems], Caspr1 (Santa Cruz Biotechnology), and Caspr2 (Santa Cruz Biotechnology) and monoclonal antibodies to mouse CD24 [79; Kadmon et al (1992)], oligomannosides, HNK-1 (for reference, see Heller et al, 2003), and Lewis x (Streit et al, 1996) were used. Carbohydrates and glycoconjugates were purchased from Dextra Laboratories, peptide N-glycosidase F (PNGase F) from Roche Molecular Biochemicals, and O-sialoglycoprotein endopeptidase (OSGE) of Mannheimia hemolytica from Cedarline.…”
Section: Methodsmentioning
confidence: 99%
“…Polyclonal antibodies to mouse L1 (Chen et al, 1999), NCAM (Kadmon et al, 1992), Contactin (R&D Systems), TAG-1 [TG3, Traka et al, (2003) and from R&D Systems], Caspr1 (Santa Cruz Biotechnology), and Caspr2 (Santa Cruz Biotechnology) and monoclonal antibodies to mouse CD24 [79; Kadmon et al (1992)], oligomannosides, HNK-1 (for reference, see Heller et al, 2003), and Lewis x (Streit et al, 1996) were used. Carbohydrates and glycoconjugates were purchased from Dextra Laboratories, peptide N-glycosidase F (PNGase F) from Roche Molecular Biochemicals, and O-sialoglycoprotein endopeptidase (OSGE) of Mannheimia hemolytica from Cedarline.…”
Section: Methodsmentioning
confidence: 99%
“…The following primary antibodies were used in this study. The monoclonal antibodies were as follows: 473HD (rat IgM) (Faissner et al, 1994), 487 (L5 epitope/LeX, rat IgM) (Streit et al, 1996), RC2 (mouse IgM; Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA), O4 (mouse IgM) (Sommer and Schachner, 1981), polysialic-acid-containing neural cell adhesion molecule (PSA-NCAM) (Rougon et al, 1986), anti-nestin (mouse IgG; Chemicon, Temecula, CA), anti-␤III-tubulin (mouse IgG; Sigma, St. Louis, MO), and anti-5-bromo-2-deoxyuridine (BrdU) (mouse IgG; Roche Products, Welwyn Garden City, UK). The polyclonal antibodies (all rabbit) were against the following: DSD-1-PG/phosphacan [referred to as pk-anti-phosphacan, batch KAF 13(4)] (Faissner et al, 1994), GFAP (Dako, High Wycombe, UK), NG2 (Chemicon), brain lipid-binding protein (BLBP; gift from Dr. N. Heintz, Rockefeller University, New York, NY), and GLAST (gift from Dr. D. Pow, University of Queensland, Brisbane, Australia; or Chemicon).…”
Section: Methodsmentioning
confidence: 99%
“…2 N) cells compared with the nonselected cell population (Table 1). We also investigated the expression of the adult NSC marker LeX (Capela and Temple, 2002) as detected with mAb 487 (Streit et al, 1996). The 473HD-positive cells were significantly enriched in 487/ LeX-positive cells (Fig.…”
Section: Identification Of 473hd-expressing Cells As Mitotically Actimentioning
confidence: 99%
“…The monoclonal antibodies 487 and 473HD (kindly provided by Andreas Faissner, Ruhr University Bochum, Bochum, Germany), and polyclonal antibody against the glutamate aspartate transporter (GLAST) (kindly provided by Niels Danbolt, University of Oslo, Oslo, Norway) have been described (Faissner et al, 1994;Lehre et al, 1995;Streit et al, 1996). All commercial primary antibodies are listed in supplementary material Table S2.…”
Section: Antibodiesmentioning
confidence: 99%